PP

Pawan Pandey Kumar

Director Director DIN 05150609
DIN 05150609 First appointment Mar 2012 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2012
Shareholding value Locked Premium profile

About Pawan Pandey Kumar

Data last updated:

Pawan Pandey Kumar has 14 years in corporate governance. Formerly with 1 company, such as Fidens Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 05150609
Primary Designation Director
First Appointment 01 Mar 2012
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director01 Mar 20122012Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fidens Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pawan Pandey Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Pandey Kumar

Pawan Pandey Kumar has 14 years in corporate governance. Formerly with 1 company, such as Fidens Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Pawan Pandey Kumar is associated with 0 companies as a director.

Pawan Pandey Kumar has expertise in General Business.

Pawan Pandey Kumar has 14 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available